ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS
Provided herein are methods of treating a subject by administering a combination of an activatable cytokine construct (ACC) and a PD-1/PD-L1 pathway inhibitor in which the ACC includes: a first monomer construct including an optional first peptide mask (PM1), an optional third cleavable moiety (CM3)...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BEREZHNOY, Alexey Yevgenyevich WONG, Kenneth PAIDHUNGAT, Madan M LAPUYADE, Nicole G LE SCOLAN, Erwan WINTER, Michael B DANIEL, Dylan L CAI, Na |
| description | Provided herein are methods of treating a subject by administering a combination of an activatable cytokine construct (ACC) and a PD-1/PD-L1 pathway inhibitor in which the ACC includes: a first monomer construct including an optional first peptide mask (PM1), an optional third cleavable moiety (CM3), a first mature cytokine protein (CP1), a first cleavable moiety (CM1), and a first dimerization domain (DD1), wherein the CM1 is positioned between the CP1 and the DD1; and a second monomer construct including an optional second peptide mask (PM2), an optional forth cleavable moiety (CM4), a second mature cytokine protein (CP2), a second cleavable moiety (CM2), and a second dimerization domain (DD2), wherein the CM2 is positioned between the CP2 and the DD2; wherein the DD1 and the DD2 bind to each other thereby forming a dimer of the first monomer construct and the second monomer construct; and where the ACC is characterized by a reduction in at least one activity of the CP1 and/or CP2 as compared to a control level of the at least one activity of the CP1 and/or CP2. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2022360371A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2022360371A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2022360371A13</originalsourceid><addsrcrecordid>eNrjZDB3dA7xDHMMcXTycVVwjgzx9_b0AzL8_YJDgkKdQ4IVHP1cgFxfJ08_xxBPfz8FX9cQD3-XYB4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEu8YamRgZGRsZmBsbuhoaEycKgD5HCk6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS</title><source>esp@cenet</source><creator>BEREZHNOY, Alexey Yevgenyevich ; WONG, Kenneth ; PAIDHUNGAT, Madan M ; LAPUYADE, Nicole G ; LE SCOLAN, Erwan ; WINTER, Michael B ; DANIEL, Dylan L ; CAI, Na</creator><creatorcontrib>BEREZHNOY, Alexey Yevgenyevich ; WONG, Kenneth ; PAIDHUNGAT, Madan M ; LAPUYADE, Nicole G ; LE SCOLAN, Erwan ; WINTER, Michael B ; DANIEL, Dylan L ; CAI, Na</creatorcontrib><description>Provided herein are methods of treating a subject by administering a combination of an activatable cytokine construct (ACC) and a PD-1/PD-L1 pathway inhibitor in which the ACC includes: a first monomer construct including an optional first peptide mask (PM1), an optional third cleavable moiety (CM3), a first mature cytokine protein (CP1), a first cleavable moiety (CM1), and a first dimerization domain (DD1), wherein the CM1 is positioned between the CP1 and the DD1; and a second monomer construct including an optional second peptide mask (PM2), an optional forth cleavable moiety (CM4), a second mature cytokine protein (CP2), a second cleavable moiety (CM2), and a second dimerization domain (DD2), wherein the CM2 is positioned between the CP2 and the DD2; wherein the DD1 and the DD2 bind to each other thereby forming a dimer of the first monomer construct and the second monomer construct; and where the ACC is characterized by a reduction in at least one activity of the CP1 and/or CP2 as compared to a control level of the at least one activity of the CP1 and/or CP2.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240502&DB=EPODOC&CC=AU&NR=2022360371A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240502&DB=EPODOC&CC=AU&NR=2022360371A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BEREZHNOY, Alexey Yevgenyevich</creatorcontrib><creatorcontrib>WONG, Kenneth</creatorcontrib><creatorcontrib>PAIDHUNGAT, Madan M</creatorcontrib><creatorcontrib>LAPUYADE, Nicole G</creatorcontrib><creatorcontrib>LE SCOLAN, Erwan</creatorcontrib><creatorcontrib>WINTER, Michael B</creatorcontrib><creatorcontrib>DANIEL, Dylan L</creatorcontrib><creatorcontrib>CAI, Na</creatorcontrib><title>ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS</title><description>Provided herein are methods of treating a subject by administering a combination of an activatable cytokine construct (ACC) and a PD-1/PD-L1 pathway inhibitor in which the ACC includes: a first monomer construct including an optional first peptide mask (PM1), an optional third cleavable moiety (CM3), a first mature cytokine protein (CP1), a first cleavable moiety (CM1), and a first dimerization domain (DD1), wherein the CM1 is positioned between the CP1 and the DD1; and a second monomer construct including an optional second peptide mask (PM2), an optional forth cleavable moiety (CM4), a second mature cytokine protein (CP2), a second cleavable moiety (CM2), and a second dimerization domain (DD2), wherein the CM2 is positioned between the CP2 and the DD2; wherein the DD1 and the DD2 bind to each other thereby forming a dimer of the first monomer construct and the second monomer construct; and where the ACC is characterized by a reduction in at least one activity of the CP1 and/or CP2 as compared to a control level of the at least one activity of the CP1 and/or CP2.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB3dA7xDHMMcXTycVVwjgzx9_b0AzL8_YJDgkKdQ4IVHP1cgFxfJ08_xxBPfz8FX9cQD3-XYB4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEu8YamRgZGRsZmBsbuhoaEycKgD5HCk6</recordid><startdate>20240502</startdate><enddate>20240502</enddate><creator>BEREZHNOY, Alexey Yevgenyevich</creator><creator>WONG, Kenneth</creator><creator>PAIDHUNGAT, Madan M</creator><creator>LAPUYADE, Nicole G</creator><creator>LE SCOLAN, Erwan</creator><creator>WINTER, Michael B</creator><creator>DANIEL, Dylan L</creator><creator>CAI, Na</creator><scope>EVB</scope></search><sort><creationdate>20240502</creationdate><title>ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS</title><author>BEREZHNOY, Alexey Yevgenyevich ; WONG, Kenneth ; PAIDHUNGAT, Madan M ; LAPUYADE, Nicole G ; LE SCOLAN, Erwan ; WINTER, Michael B ; DANIEL, Dylan L ; CAI, Na</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2022360371A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BEREZHNOY, Alexey Yevgenyevich</creatorcontrib><creatorcontrib>WONG, Kenneth</creatorcontrib><creatorcontrib>PAIDHUNGAT, Madan M</creatorcontrib><creatorcontrib>LAPUYADE, Nicole G</creatorcontrib><creatorcontrib>LE SCOLAN, Erwan</creatorcontrib><creatorcontrib>WINTER, Michael B</creatorcontrib><creatorcontrib>DANIEL, Dylan L</creatorcontrib><creatorcontrib>CAI, Na</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BEREZHNOY, Alexey Yevgenyevich</au><au>WONG, Kenneth</au><au>PAIDHUNGAT, Madan M</au><au>LAPUYADE, Nicole G</au><au>LE SCOLAN, Erwan</au><au>WINTER, Michael B</au><au>DANIEL, Dylan L</au><au>CAI, Na</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS</title><date>2024-05-02</date><risdate>2024</risdate><abstract>Provided herein are methods of treating a subject by administering a combination of an activatable cytokine construct (ACC) and a PD-1/PD-L1 pathway inhibitor in which the ACC includes: a first monomer construct including an optional first peptide mask (PM1), an optional third cleavable moiety (CM3), a first mature cytokine protein (CP1), a first cleavable moiety (CM1), and a first dimerization domain (DD1), wherein the CM1 is positioned between the CP1 and the DD1; and a second monomer construct including an optional second peptide mask (PM2), an optional forth cleavable moiety (CM4), a second mature cytokine protein (CP2), a second cleavable moiety (CM2), and a second dimerization domain (DD2), wherein the CM2 is positioned between the CP2 and the DD2; wherein the DD1 and the DD2 bind to each other thereby forming a dimer of the first monomer construct and the second monomer construct; and where the ACC is characterized by a reduction in at least one activity of the CP1 and/or CP2 as compared to a control level of the at least one activity of the CP1 and/or CP2.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2022360371A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A27%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BEREZHNOY,%20Alexey%20Yevgenyevich&rft.date=2024-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2022360371A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |